2023 - Research.com Immunology in Germany Leader Award
The scientist’s investigation covers issues in Epitope, Antigen, Immunology, Peptide and Major histocompatibility complex. His Epitope research incorporates themes from T lymphocyte, Virology, CD8, Human leukocyte antigen and Cytotoxic T cell. Stefan Stevanovic interconnects Cancer research, T cell, Immune system, Immunotherapy and Vaccination in the investigation of issues within Antigen.
His Immunology research includes elements of Ex vivo, Internal medicine and Oncology. His research integrates issues of Amino acid, Genetics and Gene in his study of Peptide. His Major histocompatibility complex research is multidisciplinary, relying on both Plasma protein binding, Computational biology and Antigen presentation.
Immunology, Antigen, Epitope, Human leukocyte antigen and T cell are his primary areas of study. His biological study spans a wide range of topics, including Cytotoxic T cell and Transplantation. His work carried out in the field of Antigen brings together such families of science as Cancer research and Immune system, Tumor antigen, Immunotherapy.
His research in Epitope intersects with topics in Virology, MHC class I, CD8, Major histocompatibility complex and Molecular biology. His study looks at the intersection of Major histocompatibility complex and topics like Peptide with Amino acid, Peptide sequence, Genetics and Peptide binding. His Human leukocyte antigen research integrates issues from Leukemia and Myeloid leukemia.
His main research concerns Human leukocyte antigen, Antigen, T cell, Cancer research and Immunotherapy. Stefan Stevanovic has researched Antigen in several fields, including Cytotoxic T cell, Chronic lymphocytic leukemia, Peptide and Cancer immunotherapy. His T cell study incorporates themes from Epitope, Peripheral blood mononuclear cell, CD8 and Virology.
His Epitope research is under the purview of Immunology. His Cancer research study integrates concerns from other disciplines, such as Cancer, Immune system and Antigen presentation. His Antigen presentation research incorporates themes from MHC class I, Major histocompatibility complex and Oncolytic virus.
His primary areas of study are Human leukocyte antigen, Antigen, T cell, Cancer research and Immunotherapy. He has included themes like Epitope, Melanoma, Computational biology and Immune system in his Human leukocyte antigen study. In his study, Immunity, Subdominant, Virology and T-Cell Epitopes is inextricably linked to Heterologous, which falls within the broad field of T cell.
His studies deal with areas such as Cancer, CD8, Antigen presentation and Immunogenicity as well as Cancer research. Stefan Stevanovic combines subjects such as Tumor Escape and MHC class I, Major histocompatibility complex with his study of Antigen presentation. His work on Cytotoxic T cell expands to the thematically related Immunotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
SYFPEITHI: database for MHC ligands and peptide motifs.
H. G. Rammensee;J. Bachmann;N. P. N. Emmerich;O. A. Bachor.
MHC ligands and peptide motifs: first listing.
Hans-Georg Rammensee;Thomas Friede;Stefan Stevanović.
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter;Toni Weinschenk;Arnulf Stenzl;Romuald Zdrojowy.
Nature Medicine (2012)
Dermcidin: a novel human antibiotic peptide secreted by sweat glands.
Birgit Schittek;Rainer Hipfel;Birgit Sauer;Jürgen Bauer.
Nature Immunology (2001)
Autophagy promotes MHC class II presentation of peptides from intracellular source proteins
Jörn Dengjel;Oliver Schoor;Rainer Fischer;Michael Reich.
Unexpected Abundance of HLA Class II Presented Peptides in Primary Renal Cell Carcinomas
Jörn Dengjel;Maria-Dorothea Nastke;Cécile Gouttefangeas;Gitsios Gitsioudis.
Clinical Cancer Research (2006)
Cutting Edge: Predetermined Avidity of Human CD8 T Cells Expanded on Calibrated MHC/Anti-CD28-Coated Microspheres
Steffen Walter;Leah Herrgen;Oliver Schoor;Gundram Jung.
Journal of Immunology (2003)
Identification of HLA-A2–Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies
Peter Brossart;Kathrin S. Heinrich;Gernot Stuhler;Lars Behnke.
Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).
Andrew Godkin;Thomas Friede;Miles Davenport;Stefan Stevanovic.
International Immunology (1997)
Exact prediction of a natural T cell epitope.
Olaf Rötzschke;Kirsten Falk;Stefan Stevanovic;Günther Jung.
European Journal of Immunology (1991)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: